AEON Biopharma, Inc.
AEON- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001837607
Insider trades, last 90 days
1 buy · 0 sells
- Bought $243.46K
- Open-market purchases (P) and sales (S), counted by Form 4 filing.
13F holders, Q2 2026
22
- −2 vs. Q1 2026
- Total value $9.22M
Superinvestors holding AEON
0
- None of the superinvestors held AEON at the end of Q2 2026.
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by AEON insiders, newest first.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 20267:41 PM ET | Aug 19, 2026 | LYNCH TIMOTHY P10% Owner | PPurchaseClass A Common Stock | +1.15M | $0.2117 | +$243.46K | 6.5M | +21.5% | SEC |
| May 23, 20254:46 PM ET | May 21, 2025 | FISCHER JOSTDirector | PPurchaseClass A Common Stock | +60K | $0.4875 | +$29.25K | 266.79K | +29.0% | SEC |
| May 21, 2025 | May 19 – May 20, 2025 | FISCHER JOSTDirector | PPurchaseClass A Common Stock | +110K | $0.5055 | +$55.6K | 206.79K | +113.7% | SEC |
| Aug 14, 2023 | Aug 11, 2023 | Strathspey Crown Holdings Group, LLC10% Owner | SSaleClass A Common Stock | −7.38M | $10.00 | −$73.8M | 2.03M | −78.4% | SEC |
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in AEON at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Dauntless Investment Group, LLC | 12,490,154 | $8.98M | 15.58% | +9,962,379+394.1% | Added |
| GEODE CAPITAL MANAGEMENT, LLC | 95,311 | $68.56K | 0.00% | +8,249+9.5% | Added |
| VANGUARD CAPITAL MANAGEMENT LLC | 90,529 | $65.09K | 0.00% | 00.0% | Unchanged |
| Blue Owl Capital Holdings LP | 42,353 | $30.49K | 0.00% | 00.0% | Unchanged |
| Formidable Asset Management, LLC | 20,024 | $19.72K | 0.00% | 00.0% | Unchanged |